Brynmor A. Watkins - Concepedia

Concepedia

Author

Brynmor A. Watkins

National Cancer Institute

Also Known As

B A Watkins, B Watkins, B. A. WATKINS, B. A. Watkins, B. Watkins, B.A. Watkins, Brynmor A Watkins, Brynmor A. Watkins, Brynmor Watkins

46

Publications

1.5K

Citations

16

H-Index

67

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Dana-Farber Cancer Institute Dana-Farber/Harvard Cancer Center Sepragen Corporation (United States)

BA

About

Brynmor A. Watkins is an author at National Cancer Institute specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.2K
2	Health Sciences	2	2	39
3	Engineering	1	1	12
4	Language Studies	1	1	18
5	Social Sciences	1	1	340

Brynmor A. Watkins

×

20

Publications

1.5K

Citations

16

H-Index

	Year	Citations
Specific Tropism of HIV-1 for Microglial Cells in Primary Human Brain Cultures Brynmor A. Watkins, Henry H. Dorn, Walter B. Kelly, Science ImmunologyHuman Immunodeficiency VirusSocial SciencesNeuroinflammationNeurobiology Of Disease	1990	340
Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients Stephen T. Sonis, Brynmor A. Watkins, Gregory D. Lyng, Oral Oncology Bone DiseaseZoledronic AcidBone HealthBony ChangesBone Metabolism	2008	208
Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent Craig Jordan, Brynmor A. Watkins, Conrad Kufta, Journal of Virology ImmunologyHuman Immunodeficiency VirusImmunotherapyBrain Microglial CellsNeuroinflammation	1991	186
AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis Silvia Caluwaerts, Klaas Vandenbroucke, Lothar Steidler, Oral Oncology Medical MicrobiologyProbioticAntimicrobial SusceptibilityOral MicrobiologyMouth Rinse Formulation	2010	128
Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers S. Sonis, Robert I. Haddad, Marshall R. Posner, Oral Oncology Biological MechanismsOncologyOncogenic AgentMedicineTreatment Resistance	2006	104
Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in Hamsters Christopher K. Murphy, Edward G. Fey, Brynmor A. Watkins, Clinical Cancer Research	2008	83
Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites Brynmor A. Watkins, Suzan L. Buge, Kristine Aldrich, Journal of Virology Antibody BindingImmunologyMolecular BiologyAntiviral DrugViral Structural Protein	1996	68
ANTIGENIC EXPRESSION BY CELLS DERIVED FROM HUMAN GLIOMAS DOES NOT CORRELATE WITH MORPHOLOGICAL CLASSIFICATION Peter G. E. Kennedy, Brynmor A. Watkins, D. G. T. Thomas, Neuropathology and Applied Neurobiology	1987	58
Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways Brynmor A. Watkins, M S Reitz, Carolyn A. Wilson, Journal of Virology ImmunologyMolecular BiologyAntigen ProcessingViral Structural ProteinImmunotherapy	1993	57
Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis Lynne A. Murray, Michael S. Kramer, David P. Hesson, Fibrogenesis & Tissue Repair	2010	41

Page 1